Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

7,425 total articles

Everyman Media Group posts revenue and EBITDA gains as net debt edges higher

Everyman Media Group posts revenue and EBITDA gains as net debt edges higher

Everyman Media Group reported an 8.7% increase in revenue to £116.5 million for the 52 weeks ended January 1, 2026, with admissions, average ticket price and food-and-beverage spend per head all higher year-on-year. Group EBITDA rose 4.9% to £17.0 million. The operator added two venues during the period, bringing its estate to 49 locations and 171 …

Tokyo stocks close higher as Nikkei rises 0.77% on sector gains

Tokyo stocks close higher as Nikkei rises 0.77% on sector gains

Tokyo markets finished higher on Tuesday, with the Nikkei 225 up 0.77% as gains in Real Estate, Banking and Textile sectors supported the advance. Several individual names posted notable moves, including Resonac, Advantest and Nissui on the upside, while Tokyo Electric Power and other industrials lagged. Market breadth showed more decliners than ad…

UK Conservatives and Former Officials Urge CMA to Open Full Probe of Netflix's $83 Billion Bid for Warner Bros Discovery

UK Conservatives and Former Officials Urge CMA to Open Full Probe of Netflix's $83 Billion Bid for Warner Bros Discovery

More than a dozen current and former UK politicians have asked the Competition and Markets Authority (CMA) to undertake a full competition inquiry into Netflix's proposed $83 billion acquisition of Warner Bros Discovery, arguing the deal risks reinforcing an already dominant player in the TV streaming market and could substantially lessen competiti…

Roche’s CT-388 Produces Large Placebo-Adjusted Weight Loss in Phase II; Phase III Set to Begin This Quarter

Roche’s CT-388 Produces Large Placebo-Adjusted Weight Loss in Phase II; Phase III Set to Begin This Quarter

Roche announced positive Phase II findings for CT-388, a dual GLP-1/GIP receptor agonist for people living with obesity. The investigational therapy delivered a 22.5% placebo-adjusted weight loss at 48 weeks and saw 54% of participants on the 24 mg dose reach resolution of obesity. Safety and tolerability were reported as generally consistent with …

ASML Accelerates Output as Chipmakers Scale AI-Driven Spend

ASML Accelerates Output as Chipmakers Scale AI-Driven Spend

ASML, the Netherlands-based producer of extreme ultraviolet lithography systems, has seen a surge in its stock and market value as chipmakers boost capital spending to meet demand for AI-capable processors. The company, the sole supplier of EUV tools, dominates high-end lithography and is preparing to report results amid investor scrutiny over whet…

India and EU Seal Major Trade Accord, Paving Way for Broader Market Access

India and EU Seal Major Trade Accord, Paving Way for Broader Market Access

India and the European Union have finalised a comprehensive trade agreement that Indian Prime Minister Narendra Modi described as transformative for both economies. The pact, representing roughly 25% of global GDP and about one-third of global trade, will open India's protected market to the 27-nation EU. Leaders are scheduled to present the agreem…